GLP-1-话题@MedSci

#GLP-1#

111篇内容 | 2162人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1422707, encodeId=3e7b1422e0782, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=JCEM：单剂量二甲双胍增强2型糖尿病患者胆汁酸诱导的GLP-1分泌, objectType=article, longId=111632, objectId=9fb711163273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fb711163273, replyNumber=0, likeNumber=30, createdTime=2017-09-03, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fb711163273, moduleTitle=JCEM：单剂量二甲双胍增强2型糖尿病患者胆汁酸诱导的GLP-1分泌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fb711163273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422706, encodeId=a50b1422e0615, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetologia：GLP-1信号传导补偿βIRKO小鼠调节β细胞增殖的胰岛素信号受损, objectType=article, longId=107459, objectId=57e910e45950, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57e910e45950, replyNumber=0, likeNumber=33, createdTime=2017-08-03, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57e910e45950, moduleTitle=Diabetologia：GLP-1信号传导补偿βIRKO小鼠调节β细胞增殖的胰岛素信号受损, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57e910e45950)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422705, encodeId=f7e91422e0537, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetes Obes Metab：早期2型糖尿病患者使用利拉鲁肽或增强内源性GLP-1分泌应答, objectType=article, longId=98775, objectId=597598e7571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597598e7571, replyNumber=0, likeNumber=26, createdTime=2017-05-17, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597598e7571, moduleTitle=Diabetes Obes Metab：早期2型糖尿病患者使用利拉鲁肽或增强内源性GLP-1分泌应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=597598e7571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422704, encodeId=0e751422e04db, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=FASEB J：糖尿病治疗新进展：双肽PGLP-1有效增强胰岛素敏感性！, objectType=article, longId=98643, objectId=5c23986433d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c23986433d, replyNumber=0, likeNumber=23, createdTime=2017-05-14, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c23986433d, moduleTitle=FASEB J：糖尿病治疗新进展：双肽PGLP-1有效增强胰岛素敏感性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c23986433d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422703, encodeId=591f1422e031c, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetes：Neurturin和GLP-1类似物协同作用缓解Zucker糖尿病肥胖大鼠糖尿病！, objectType=article, longId=96123, objectId=b2de961238c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2de961238c, replyNumber=0, likeNumber=45, createdTime=2017-04-19, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2de961238c, moduleTitle=Diabetes：Neurturin和GLP-1类似物协同作用缓解Zucker糖尿病肥胖大鼠糖尿病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2de961238c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422702, encodeId=aedc1422e02df, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次, objectType=article, longId=95493, objectId=77e9954938e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77e9954938e, replyNumber=0, likeNumber=29, createdTime=2017-04-13, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77e9954938e, moduleTitle=Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77e9954938e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422701, encodeId=d3281422e01a1, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetes Care：GLP-1受体激动剂dulaglutide治疗的胰腺安全评估分析！, objectType=article, longId=91502, objectId=711891502a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=711891502a5, replyNumber=0, likeNumber=27, createdTime=2017-03-13, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=711891502a5, moduleTitle=Diabetes Care：GLP-1受体激动剂dulaglutide治疗的胰腺安全评估分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=711891502a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422699, encodeId=3a641422699c6, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, objectType=article, longId=78308, objectId=7164e8308d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7164e8308d1, replyNumber=0, likeNumber=14, createdTime=2016-09-25, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7164e8308d1, moduleTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7164e8308d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422700, encodeId=71301422e0025, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=EASD 2016：诺和诺德长效GLP-1降糖药semaglutide三大功效：降糖，减肥，降低心血管风险, objectType=article, longId=78310, objectId=11a0e8310ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11a0e8310ab, replyNumber=0, likeNumber=36, createdTime=2016-09-25, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11a0e8310ab, moduleTitle=EASD 2016：诺和诺德长效GLP-1降糖药semaglutide三大功效：降糖，减肥，降低心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11a0e8310ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422698, encodeId=23d4142269858, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Clin Nutr：GLP-1和GLP-2调节肠衰竭患儿的肠道适应性, objectType=article, longId=77533, objectId=ed51e75334a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed51e75334a, replyNumber=0, likeNumber=31, createdTime=2016-09-17, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed51e75334a, moduleTitle=Clin Nutr：GLP-1和GLP-2调节肠衰竭患儿的肠道适应性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed51e75334a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422697, encodeId=ef63142269e11, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=JAMA Intern Med：GLP-1类似物会增加胆管和胆囊疾病风险, objectType=article, longId=74513, objectId=a4c4e4513ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4c4e4513ef, replyNumber=0, likeNumber=28, createdTime=2016-08-07, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4c4e4513ef, moduleTitle=JAMA Intern Med：GLP-1类似物会增加胆管和胆囊疾病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4c4e4513ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422696, encodeId=28831422696fe, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Cell子刊综述总结肠分泌激素GLP-1参与的心血管生物学, objectType=article, longId=72298, objectId=e2a5e229887, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2a5e229887, replyNumber=0, likeNumber=36, createdTime=2016-07-09, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2a5e229887, moduleTitle=Cell子刊综述总结肠分泌激素GLP-1参与的心血管生物学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2a5e229887)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422695, encodeId=279a142269568, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=长效GLP-1降糖药semaglutide显著降低2型糖尿病患者重大心血管事件风险（SUSTAIN 6研究）, objectType=article, longId=67351, objectId=ce4c6e35197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce4c6e35197, replyNumber=0, likeNumber=16, createdTime=2016-05-01, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce4c6e35197, moduleTitle=长效GLP-1降糖药semaglutide显著降低2型糖尿病患者重大心血管事件风险（SUSTAIN 6研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce4c6e35197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422694, encodeId=0a021422694bf, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=AIM：GLP-1RAs治疗2型糖尿病—受益和损害, objectType=article, longId=60432, objectId=0aae6043274, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aae6043274, replyNumber=0, likeNumber=36, createdTime=2015-12-10, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aae6043274, moduleTitle=AIM：GLP-1RAs治疗2型糖尿病—受益和损害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0aae6043274)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422693, encodeId=1db3142269360, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=NEJM新闻：快讯！每周一次GLP-1RAs，治疗2型糖尿病, objectType=article, longId=60426, objectId=1e26604262f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e26604262f, replyNumber=0, likeNumber=15, createdTime=2015-12-10, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e26604262f, moduleTitle=NEJM新闻：快讯！每周一次GLP-1RAs，治疗2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e26604262f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422692, encodeId=1801142269290, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Addict Biology： GLP-1样药物可用于治疗酒精依赖症, objectType=article, longId=56667, objectId=2b575666eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b575666eaf, replyNumber=0, likeNumber=0, createdTime=2015-09-29, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b575666eaf, moduleTitle=Addict Biology： GLP-1样药物可用于治疗酒精依赖症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b575666eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422691, encodeId=a838142269165, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=ADA 2015：GLP-1类药物降低体重的奥秘——影响大脑对食物的反应, objectType=article, longId=51987, objectId=57f45198e5d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57f45198e5d, replyNumber=0, likeNumber=44, createdTime=2015-06-13, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57f45198e5d, moduleTitle=ADA 2015：GLP-1类药物降低体重的奥秘——影响大脑对食物的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57f45198e5d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422690, encodeId=f27d142269083, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetes：GLP-1五肽小分子可抑制肥胖, objectType=article, longId=49422, objectId=7c7e4942222, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c7e4942222, replyNumber=0, likeNumber=30, createdTime=2015-04-17, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c7e4942222, moduleTitle=Diabetes：GLP-1五肽小分子可抑制肥胖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c7e4942222)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422689, encodeId=2a60142268903, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=JECM：GLP-1敏感性存在个体差异，与胰岛素抵抗无关, objectType=article, longId=49041, objectId=c1294904172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1294904172, replyNumber=0, likeNumber=25, createdTime=2015-04-09, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1294904172, moduleTitle=JECM：GLP-1敏感性存在个体差异，与胰岛素抵抗无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1294904172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422688, encodeId=ec181422688fd, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetologia：GLP-1联合雌激素，可以阻止胰岛B细胞功能衰竭, objectType=article, longId=45367, objectId=d24a4536e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d24a4536e71, replyNumber=0, likeNumber=30, createdTime=2015-01-14, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d24a4536e71, moduleTitle=Diabetologia：GLP-1联合雌激素，可以阻止胰岛B细胞功能衰竭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d24a4536e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

GLP-1

2020-05-29

yibei (审核中...)

前往app查看评论内容

#GLP-1#

JCEM：单剂量二甲双胍增强2型糖尿病患者胆汁酸诱导的GLP-1分泌

2017-09-03

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetologia：GLP-1信号传导补偿βIRKO小鼠调节β细胞增殖的胰岛素信号受损

2017-08-03

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetes Obes Metab：早期2型糖尿病患者使用利拉鲁肽或增强内源性GLP-1分泌应答

2017-05-17

yibei (审核中...)

前往app查看评论内容

#GLP-1#

FASEB J：糖尿病治疗新进展：双肽PGLP-1有效增强胰岛素敏感性！

2017-05-14

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetes：Neurturin和GLP-1类似物协同作用缓解Zucker糖尿病肥胖大鼠糖尿病！

2017-04-19

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次

2017-04-13

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetes Care：GLP-1受体激动剂dulaglutide治疗的胰腺安全评估分析！

2017-03-13

yibei (审核中...)

前往app查看评论内容

#GLP-1#

EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压

2016-09-25

yibei (审核中...)

前往app查看评论内容

#GLP-1#

EASD 2016：诺和诺德长效GLP-1降糖药semaglutide三大功效：降糖，减肥，降低心血管风险

2016-09-25

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Clin Nutr：GLP-1和GLP-2调节肠衰竭患儿的肠道适应性

2016-09-17

yibei (审核中...)

前往app查看评论内容

#GLP-1#

JAMA Intern Med：GLP-1类似物会增加胆管和胆囊疾病风险

2016-08-07

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Cell子刊综述总结肠分泌激素GLP-1参与的心血管生物学

2016-07-09

yibei (审核中...)

前往app查看评论内容

#GLP-1#

长效GLP-1降糖药semaglutide显著降低2型糖尿病患者重大心血管事件风险（SUSTAIN 6研究）

2016-05-01

yibei (审核中...)

前往app查看评论内容

#GLP-1#

AIM：GLP-1RAs治疗2型糖尿病—受益和损害

2015-12-10

yibei (审核中...)

前往app查看评论内容

#GLP-1#

NEJM新闻：快讯！每周一次GLP-1RAs，治疗2型糖尿病

2015-12-10

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Addict Biology： GLP-1样药物可用于治疗酒精依赖症

2015-09-29

yibei (审核中...)

前往app查看评论内容

#GLP-1#

ADA 2015：GLP-1类药物降低体重的奥秘——影响大脑对食物的反应

2015-06-13

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetes：GLP-1五肽小分子可抑制肥胖

2015-04-17

yibei (审核中...)

前往app查看评论内容

#GLP-1#

JECM：GLP-1敏感性存在个体差异，与胰岛素抵抗无关

2015-04-09

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetologia：GLP-1联合雌激素，可以阻止胰岛B细胞功能衰竭

2015-01-14

科室
- - 订阅+
  - 更多科室
工具
服务